酒石酸溴莫尼定结构式
|
常用名 | 酒石酸溴莫尼定 | 英文名 | Brimonidine L-tartrate |
---|---|---|---|---|
CAS号 | 70359-46-5 | 分子量 | 442.221 | |
密度 | N/A | 沸点 | 432.6ºC at 760 mmHg | |
分子式 | C15H16BrN5O6 | 熔点 | 207-208ºC (dec.) | |
MSDS | N/A | 闪点 | 215.4ºC | |
符号 |
GHS06 |
信号词 | Danger |
酒石酸溴莫尼定用途UK 14,304是_alpha_2-adrenergic receptor (_alpha_2-AR)受体激动剂。 |
中文名 | 酒石酸溴莫尼定 |
---|---|
英文名 | 5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)-6-Quinoxalinamine Tartrate |
中文别名 | 5-溴-6-(咪唑啉-2-基)氨基喹喔啉酒石酸盐 | 溴莫尼定酒石酸盐 |
英文别名 | 更多 |
描述 | UK 14,304是_alpha_2-adrenergic receptor (_alpha_2-AR)受体激动剂。 |
---|---|
相关类别 | |
参考文献 |
沸点 | 432.6ºC at 760 mmHg |
---|---|
熔点 | 207-208ºC (dec.) |
分子式 | C15H16BrN5O6 |
分子量 | 442.221 |
闪点 | 215.4ºC |
精确质量 | 441.028381 |
PSA | 177.26000 |
外观性状 | 奶油色-淡黄色粉末 |
储存条件 | -20°C Freezer |
符号 |
GHS06 |
---|---|
信号词 | Danger |
危害声明 | H301-H315-H319-H335 |
警示性声明 | Missing Phrase - N15.00950417-P305 + P351 + P338 |
安全声明 (欧洲) | S36/37 |
危险品运输编码 | UN 2811 6.1 / PGIII |
海关编码 | 2933990090 |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.
J. Refract. Surg. 29(7) , 469-75, (2013) To investigate whether dilute brimonidine (0.025%) reduces patient discomfort, subconjunctival hemorrhage, and injection after LASIK without a significant increase in the rate of flap complications or... |
|
Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.
Invest. Ophthalmol. Vis. Sci. 55(11) , 7387-97, (2014) In this work, we tested the hypothesis that highly targeted delivery of antiglaucoma drugs to the supraciliary space by using a hollow microneedle allows dramatic dose sparing of the drug compared to ... |
|
Determinants and characteristics of angle-closure disease in an elderly Chinese population.
Ophthalmic Epidemiol. 22(2) , 109-15, (2015) To determine factors associated with angle-closure disease, particularly in those with structural or functional damage to the eyes, in an elderly Chinese population.A total of 460 individuals aged ove... |
Brimonidine tartrate |
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine tartrate |
(2R,3R)-2,3-Dihydroxysuccinic acid - 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (1:1) |
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-tartrate |
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine, (2R,3R)-2,3-dihydroxybutanedioate |
Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (1:1) |
MFCD07773086 |
UK 14,304 (tartrate) |